New Alzheimer's drug repairs DNA damage and reduces brain inflammation
Researchers at King’s College London report that KCL-286, an experimental drug originally developed for spinal cord injury, may offer a new way to treat Alzheimer’s disease. In mouse studies, the oral...
Jonathan Corcoran · Maria Goncalves · King's College London · Institute of Psychiatry, Psychology & Neuroscience